Moreover, NCL was validated as a target of curcumol in nasopharyngeal carcinoma (NPC) cells, through cellular thermal shift assay (CETSA), molecular docking (7.8 kcal/mol binding free energy) and cell‐based assay. This evidence concerns the gene NUCLEOLIN and nasopharyngeal carcinoma.